Acurx Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ACXP Nasdaq 2836 www.acurxpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Acurx Pharmaceuticals, Inc.

New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V. - Jun 27th, 2025 10:35 am
/C O R R E C T I O N -- Acurx Pharmaceuticals, Inc./ - Jun 18th, 2025 6:00 pm
Are Medical Stocks Lagging Acurx Pharmaceuticals (ACXP) This Year? - Jun 18th, 2025 7:40 am
Sector Update: Health Care Stocks Retreat Late Afternoon - Jun 17th, 2025 1:53 pm
Acurx Announces Publication in Lancet Microbe of Phase 2b Clinical Trial Data for Ibezapolstat in CDI - Jun 17th, 2025 5:01 am
New to The Street's Documentary Specials Break Records: IMG Academy Surpasses 126,000 Views in Just 12 Days - Jun 9th, 2025 7:00 am
Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Federation of American Societies for Experimental Biology Scientific Conference - Jun 9th, 2025 5:30 am
Acurx Pharmaceuticals, Inc. Reports First Quarter Results and Provides Business Update - May 13th, 2025 5:01 am
Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update - Apr 30th, 2025 5:30 am
Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase - Apr 28th, 2025 5:30 am
Indian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors - Apr 17th, 2025 5:30 am
New to The Street Renews Acurx Pharmaceuticals (NASDAQ: ACXP) for Exclusive 6-Month Media Series Including Nationwide TV, Earned Media, and Expanded Digital Reach - Apr 16th, 2025 10:45 am
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President Tyler Korman - as Sponsored Programming - Apr 12th, 2025 7:45 am
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BIOVie’s Dr. Joe Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President Tyler Korman — as Sponsored Programming - Apr 11th, 2025 2:45 pm
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President Tyler Korman - as Sponsored Programming - Apr 11th, 2025 10:45 am
Acurx Pharmaceuticals (ACXP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Apr 8th, 2025 7:55 am
Acurx Pharmaceuticals, Inc. (ACXP): Insider Were Buying In Q1 2025 - Apr 2nd, 2025 1:30 pm
Acurx Pharmaceuticals Inc (ACXP) Q4 2024 Earnings Call Highlights: Advancing Antibiotic Trials ... - Mar 23rd, 2025 7:00 pm
Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know - Mar 21st, 2025 10:00 am
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - Mar 18th, 2025 5:01 am